AFP and hepatocellular carcinoma: Lastly, the diagnostic performance of MDK in detecting HCC in patients with negative AFP was 85% sensitivity and 88% specificity, making MDK a good candidate for detecting very early, early, and, in some cases, AFP-negative HCC.